The alkaloids camptothecin and topotecan, which reportedly interacted with G-quadruplex regions of the MYB promoter and led to MYB suppression, also suppressed MYBL2 and MYCN expression in IMR-32, Kelly, and LAN-5 neuroblastoma cells accompanied by apoptosis induction[223]. The gene discussed is MYB; the disease is neuroblastoma.